The effects of reproductive hormones on the physical properties of cervicovaginal fluid

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 3, 2014, Pages 226.e1-226.e7

  Chappell, Catherine A ^a   Rohan, Lisa C ^b   Moncla, Bernard J ^a,b   Wang, Lin ^b   Meyn, Leslie A ^b   Bunge, Katherine ^a,b   Hillier, Sharon L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

bacterial vaginosis; cervicovaginal fluid; contraceptives

Indexed keywords

DEPOT MEDROXYPROGESTERONE ACETATE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL VAGINOSIS; CERVICOVAGINAL FLUID; CERVICOVAGINAL LAVAGE; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; DENSITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; NUGENT SCORE; OSMOLALITY; PH; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN CONTENT; SCORING SYSTEM; VAGINA DISCHARGE; VAGINA DISEASE; VAGINA FLORA; VAGINA SMEAR; VAGINAL LAVAGE; VISCOSITY;

BACTERIAL VAGINOSIS; CERVICOVAGINAL FLUID; CONTRACEPTIVES;

ADOLESCENT; ADULT; BODY FLUIDS; CERVIX UTERI; CONTRACEPTION; FEMALE; HUMANS; INTRAUTERINE DEVICES; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PROTEINS; VAGINA; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; VISCOSITY;

EID: 85058204939     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.03.041     Document Type: Article

References (29)

1. A.M. Cole Innate host defense of human vaginal and cervical mucosae Curr Topics Microbiol Immunol 306 2006 199 230
2. S.A. Shukair, S.A. Allen, and G.C. Cianci et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement Mucosal Immunol 6 2013 427 434
3. H. Boukari, B. Brichacek, and P. Stratton et al. Movements of HIV-virions in human cervical mucus Biomacromol 10 2009 2482 2488
4. N. Venkataraman, A.L. Cole, P. Svoboda, J. Pohl, and A.M. Cole Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid J Immunol 175 2005 7560 7567
5. E. Bard, S. Laibe, and D. Bettinger et al. New sensitive method for the measurement of lysozyme and lactoferrin for the assessment of innate mucosal immunity. part I: time-resolved immunofluorometric assay in serum and mucosal secretions Clin Chem Lab Med: CCLM / FESCC 41 2003 127 133
6. F. Groot, T.B. Geijtenbeek, and R.W. Sanders et al. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN - gp120 interaction J Virol 79 2005 3009 3015
7. T.B. McNeely, D.C. Shugars, M. Rosendahl, C. Tucker, S.P. Eisenberg, and S.M. Wahl Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription Blood 90 1997 1141 1149
8. J.A. Turpin, C.A. Schaeffer, and M. Bu et al. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor Antiviral Res 29 1996 269 277
9. M.E. Quinones-Mateu, M.M. Lederman, and Z. Feng et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication AIDS 17 2003 F39 F48
10. B. Ola, M. Afnan, S. Papaioannou, K. Sharif, L. Bjorndahl, and A. Coomarasamy Accuracy of sperm-cervical mucus penetration tests in evaluating sperm motility in semen: a systematic quantitative review Human Reprod 18 2003 1037 1046
11. J.H. Check, K. Nowroozi, and C.H. Wu et al. The use of pelvic sonography and serum estrodiol and progesterone assays in diagnosis and treatment of cervical factor Infertility 9 1986 247
12. K.S. Moghissi, and C. Marks Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium Fertil Steril 22 1971 424 434
13. I.C. Barbosa, E. Coutinho, C. Hirsch, O.A. Ladipo, S.E. Olsson, and U. Ulmsten Temporal relationship between Uniplant insertion and changes in cervical mucus Contraception 54 1996 213 217
14. C.A. Petta, A. Faundes, and T.R. Dunson et al. Timing of onset of contraceptive effectiveness in Depo-Provera users: part I, changes in cervical mucus Fertil Steril 69 1998 252 257
15. R.A. Lewis, D. Taylor, M.F. Natavio, A. Melamed, J. Felix, and D. Mishell Jr. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability Contraception 82 2010 491 496
16. M.J. Keller, E. Guzman, and E. Hazrati et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity AIDS 21 2007 467 476
17. A.E. King, D.C. Fleming, H.O. Critchley, and R.W. Kelly Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium J Reprod Immunol 59 2003 1 16
18. A.E. King, H.O. Critchley, and R.W. Kelly Innate immune defences in the human endometrium Reprod Biol Endocrinol: RB&E 1 2003 116
19. C.B. Polis, and K.M. Curtis Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence Lancet Infect Dis 13 2013 797 808
20. R. Heffron, D. Donnell, and H. Rees et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study Lancet Infect Dis 12 2012 19 26
21. J.M. Baeten, S. Benki, and V. Chohan et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women AIDS 21 2007 1771 1777
22. C.S. Morrison, P.L. Chen, and C. Kwok et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling AIDS 24 2010 1778 1781
23. J.H. van de Wijgert, C.S. Morrison, and P.G. Cornelisse et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women J Acquir Immune Defic Syndr 48 2008 203 210
24. C.R. Cohen, J.R. Lingappa, and J.M. Baeten et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples PLoS Med 9 2012 e1001251
25. S.S. Olmsted, L.A. Meyn, L.C. Rohan, and S.L. Hillier Glycosidase and proteinase activity of anaerobic Gram-negative bacteria isolated from women with bacterial vaginosis Sex Transmit Dis 30 2003 257 261
26. L. Howe, R. Wiggins, P.W. Soothill, M.R. Millar, P.J. Horner, and A.P. Corfield Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour Int J STD AIDS 10 1999 442 447
27. R.P. Nugent, M.A. Krohn, and S.L. Hillier Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation J Clin Microbiol 29 1991 297 301
28. J.L. Shaw, C.R. Smith, and E.P. Diamandis Proteomic analysis of human cervico-vaginal fluid J Proteome Res 6 2007 2859 2865
29. L.J. Tang, F. De Seta, and F. Odreman et al. Proteomic analysis of human cervical-vaginal fluids J Proteome Res 6 2007 2874 2883